Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

246 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
New-generation vaccines against cholera.
Clemens J, Shin S, Sur D, Nair GB, Holmgren J. Clemens J, et al. Among authors: sur d. Nat Rev Gastroenterol Hepatol. 2011 Nov 8;8(12):701-10. doi: 10.1038/nrgastro.2011.174. Nat Rev Gastroenterol Hepatol. 2011. PMID: 22064524 Review.
The case for reactive mass oral cholera vaccinations.
Reyburn R, Deen JL, Grais RF, Bhattacharya SK, Sur D, Lopez AL, Jiddawi MS, Clemens JD, von Seidlein L. Reyburn R, et al. Among authors: sur d. PLoS Negl Trop Dis. 2011 Jan 25;5(1):e952. doi: 10.1371/journal.pntd.0000952. PLoS Negl Trop Dis. 2011. PMID: 21283614 Free PMC article.
Risk map of cholera infection for vaccine deployment: the eastern Kolkata case.
You YA, Ali M, Kanungo S, Sah B, Manna B, Puri M, Nair GB, Bhattacharya SK, Convertino M, Deen JL, Lopez AL, Wierzba TF, Clemens J, Sur D. You YA, et al. Among authors: sur d. PLoS One. 2013 Aug 2;8(8):e71173. doi: 10.1371/journal.pone.0071173. Print 2013. PLoS One. 2013. PMID: 23936491 Free PMC article.
Efficacy and safety of a modified killed-whole-cell oral cholera vaccine in India: an interim analysis of a cluster-randomised, double-blind, placebo-controlled trial.
Sur D, Lopez AL, Kanungo S, Paisley A, Manna B, Ali M, Niyogi SK, Park JK, Sarkar B, Puri MK, Kim DR, Deen JL, Holmgren J, Carbis R, Rao R, Nguyen TV, Donner A, Ganguly NK, Nair GB, Bhattacharya SK, Clemens JD. Sur D, et al. Lancet. 2009 Nov 14;374(9702):1694-702. doi: 10.1016/S0140-6736(09)61297-6. Epub 2009 Oct 8. Lancet. 2009. PMID: 19819004 Clinical Trial.
Oral cholera vaccines--a call for action.
Sur D, Nair GB, Lopez AL, Clemens JD, Katoch VM, Ganguly NK. Sur D, et al. Indian J Med Res. 2010 Jan;131:1-3. Indian J Med Res. 2010. PMID: 20167966 Free article. No abstract available.
Efficacy of a low-cost, inactivated whole-cell oral cholera vaccine: results from 3 years of follow-up of a randomized, controlled trial.
Sur D, Kanungo S, Sah B, Manna B, Ali M, Paisley AM, Niyogi SK, Park JK, Sarkar B, Puri MK, Kim DR, Deen JL, Holmgren J, Carbis R, Rao R, Nguyen TV, Han SH, Attridge S, Donner A, Ganguly NK, Bhattacharya SK, Nair GB, Clemens JD, Lopez AL. Sur D, et al. PLoS Negl Trop Dis. 2011 Oct;5(10):e1289. doi: 10.1371/journal.pntd.0001289. Epub 2011 Oct 18. PLoS Negl Trop Dis. 2011. PMID: 22028938 Free PMC article. Clinical Trial.
5 year efficacy of a bivalent killed whole-cell oral cholera vaccine in Kolkata, India: a cluster-randomised, double-blind, placebo-controlled trial.
Bhattacharya SK, Sur D, Ali M, Kanungo S, You YA, Manna B, Sah B, Niyogi SK, Park JK, Sarkar B, Puri MK, Kim DR, Deen JL, Holmgren J, Carbis R, Dhingra MS, Donner A, Nair GB, Lopez AL, Wierzba TF, Clemens JD. Bhattacharya SK, et al. Among authors: sur d. Lancet Infect Dis. 2013 Dec;13(12):1050-6. doi: 10.1016/S1473-3099(13)70273-1. Epub 2013 Oct 18. Lancet Infect Dis. 2013. PMID: 24140390 Clinical Trial.
246 results